Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

During a live event, Jorge Monge, MD, discussed real-world evidence on the use of CAR T-cell therapy beyond the trial setting ...

Hospitals paradoxically house fast food outlets, raising health concerns. A U.S. poll shows most oppose such sales; India too ...

Panelists discuss that shifting talquetamab dosing from weekly to every 2 weeks improves response durability and patient ...